United States Drug Enforcement Administration
The U.S. Drug Enforcement Administration is warning the American public of a sharp increase in the trafficking of fentanyl mixed with xylazine. Xylazine, also known as “Tranq,” is a powerful sedative that the U.S. Food and Drug Administration has approved for veterinary use. “Xylazine is making the deadliest drug threat our country has ever faced, fentanyl, even deadlier,” said Administrator Milgram. “DEA has seized xylazine and fentanyl mixtures in 48 of 50 States. The DEA Laboratory System is reporting that in 2022 approximately 23% of fentanyl powder and 7% of fentanyl pills seized by the DEA contained xylazine.”
Center for Disease Control and Prevention
National Institute on Drug Abuse
U.S. Food and Drug Administration
Every August, SAMHSA commemorates Overdose Awareness Week (August 27 to September 2, 2023) and International Overdose Awareness Day (August 31, 2023) to remember the individuals, families, and communities who have all been impacted by overdose. According to the latest provisional data from the Centers for Disease Control and Prevention (CDC), an estimated 110,000 lives were lost to overdose in the 12-months ending in March 2023, with fentanyl and other synthetic opioids as the main drivers of these deaths. Adding to the challenge of rising fentanyl-involved overdoses is the emergence of xylazine, a non-opioid tranquilizer, increasingly mixed with fentanyl in the illicit drug supply.